BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22963934)

  • 1. Alcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana.
    Zetola NM; Modongo C; Kip EC; Gross R; Bisson GP; Collman RG
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1529-34. PubMed ID: 22963934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PREVALENCE AND FACTORS ASSOCIATED WITH MULTIDRUG-RESISTANT TUBERCULOSIS AT SIRIRAJ HOSPITAL, BANGKOK, THAILAND.
    Jitmuang A; Munjit P; Foongladda S
    Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):697-706. PubMed ID: 26867390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
    Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
    Tembo BP; Malangu NG
    BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol use disorders in multidrug resistant tuberculosis (MDR-TB) patients and their non-tuberculosis family contacts in Nigeria.
    Lasebikan VO; Ige OM
    Pan Afr Med J; 2020; 36():321. PubMed ID: 33193975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proportion of multidrug-resistant tuberculosis in human immunodeficiency virus/mycobacterium tuberculosis co-infected patients in Korea.
    Joh JS; Hong HC; Jeong IA; Chin BS; Yang HJ; Choi H; Bang JH
    J Korean Med Sci; 2012 Oct; 27(10):1143-6. PubMed ID: 23091309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
    Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.
    Walls G; Bulifon S; Breysse S; Daneth T; Bonnet M; Hurtado N; Molfino L
    Glob Health Action; 2015; 8():25964. PubMed ID: 25623609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for a population-based molecular epidemiology study of tuberculosis transmission in a high HIV-burden setting: the Botswana Kopanyo study.
    Zetola NM; Modongo C; Moonan PK; Click E; Oeltmann JE; Shepherd J; Finlay A
    BMJ Open; 2016 May; 6(5):e010046. PubMed ID: 27160840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia.
    Demile B; Zenebu A; Shewaye H; Xia S; Guadie A
    BMC Infect Dis; 2018 May; 18(1):249. PubMed ID: 29855354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Multi-Drug Resistant Tuberculosis More Prevalent in HIV-Infected Patients in Korea?
    Lee S; Lee SH; Mok JH; Lee SJ; Kim KH; Lee JE; Lee SG; Chung JS; Kwak IS
    Yonsei Med J; 2016 Nov; 57(6):1508-10. PubMed ID: 27593882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study.
    Alene KA; Viney K; McBryde ES; Gray DJ; Melku M; Clements ACA
    Transbound Emerg Dis; 2019 Jul; 66(4):1611-1618. PubMed ID: 30924283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
    Cox HS; McDermid C; Azevedo V; Muller O; Coetzee D; Simpson J; Barnard M; Coetzee G; van Cutsem G; Goemaere E
    PLoS One; 2010 Nov; 5(11):e13901. PubMed ID: 21085569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
    Park S; Jo KW; Lee SD; Kim WS; Shim TS
    Respir Med; 2017 Oct; 131():43-48. PubMed ID: 28947041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant TB and HIV in Thailand: overlapping, but not independently associated, risk factors.
    Akksilp S; Wattanaamornkiat W; Kittikraisak W; Nateniyom S; Rienthong S; Sirinak C; Ngamlert K; Mankatittham W; Sattayawuthipong W; Sumnapun S; Yamada N; Monkongdee P; Anuwatnonthakate A; Burapat C; Wells CD; Tappero JW; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):1000-14. PubMed ID: 19842383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.